Bioprocess Systems Engineering Applications in Pharmaceutical Manufacturing

Biopharmaceutical and pharmaceutical manufacturing are strongly influenced by the process analytical technology initiative (PAT) and quality by design (QbD) methodologies, which are designed to enhance the understanding of more integrated processes. The major aim of this effort can be summarized as...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Sonstige:
Year of Publication:2022
Language:English
Physical Description:1 electronic resource (226 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 04493nam-a2201033z--4500
001 993560439404498
005 20240624211541.0
006 m o d
007 cr|mn|---annan
008 202209s2022 xx |||||o ||| 0|eng d
035 |a (CKB)5680000000080798 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/92142 
035 |a (EXLCZ)995680000000080798 
041 0 |a eng 
100 1 |a Pörtner, Ralf  |4 edt 
245 1 0 |a Bioprocess Systems Engineering Applications in Pharmaceutical Manufacturing 
260 |a Basel  |b MDPI Books  |c 2022 
300 |a 1 electronic resource (226 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 |a Open access  |f Unrestricted online access  |2 star 
520 |a Biopharmaceutical and pharmaceutical manufacturing are strongly influenced by the process analytical technology initiative (PAT) and quality by design (QbD) methodologies, which are designed to enhance the understanding of more integrated processes. The major aim of this effort can be summarized as developing a mechanistic understanding of a wide range of process steps, including the development of technologies to perform online measurements and real-time control and optimization. Furthermore, minimization of the number of empirical experiments and the model-assisted exploration of the process design space are targeted. Even if tremendous progress has been achieved so far, there is still work to be carried out in order to realize the full potential of the process systems engineering toolbox. Within this reprint, an overview of cutting-edge developments of process systems engineering for biopharmaceutical and pharmaceutical manufacturing processes is given, including model-based process design, Digital Twins, computer-aided process understanding, process development and optimization, and monitoring and control of bioprocesses. The biopharmaceutical processes addressed focus on the manufacturing of biopharmaceuticals, mainly by Chinese hamster ovary (CHO) cells, as well as adeno-associated virus production and generation of cell spheroids for cell therapies. 
546 |a English 
650 7 |a Technology: general issues  |2 bicssc 
650 7 |a History of engineering & technology  |2 bicssc 
653 |a clonal cell population 
653 |a phenotypic diversity 
653 |a inoculum train 
653 |a uncertainty-based 
653 |a cell culture model 
653 |a biopharmaceutical manufacturing 
653 |a Escherichia coli 
653 |a hybrid modeling 
653 |a machine learning 
653 |a model-assisted DoE 
653 |a quality by design 
653 |a upstream bioprocessing 
653 |a surface plasmon resonance (SPR) 
653 |a bioprocess 
653 |a monitoring 
653 |a biosensor 
653 |a quality by design (QbD) 
653 |a process analytical technology (PAT) 
653 |a biotherapeutics production 
653 |a vaccines production 
653 |a CHO DP-12 
653 |a computational fluid dynamics 
653 |a bioreactor characterization 
653 |a hydrodynamic gradients 
653 |a process development 
653 |a critical shear stress 
653 |a Kolmogorov length scale 
653 |a operational space 
653 |a sensors 
653 |a cell culture 
653 |a spectroscopy 
653 |a PAT 
653 |a smart biomanufacturing 
653 |a soft-sensor 
653 |a Adeno-associated virus 
653 |a transfection 
653 |a PEI 
653 |a continuous 
653 |a gene therapy 
653 |a microcarriers 
653 |a bioreactor 
653 |a transient expression 
653 |a spheroid strength 
653 |a β-cells 
653 |a diabetes 
653 |a shear stress-guided production 
653 |a hydrodynamic stress 
653 |a Gaussian processes 
653 |a Bayes optimization 
653 |a Pareto optimization 
653 |a multi-objective 
653 |a seed train 
653 |a Chinese hamster ovary cells 
653 |a cryopreservation 
653 |a monoclonal antibodies 
653 |a N−1 perfusion 
653 |a process intensification 
653 |a upstream processing 
776 |z 3-0365-5210-3 
776 |z 3-0365-5209-X 
700 1 |a Möller, Johannes  |4 edt 
700 1 |a Pörtner, Ralf  |4 oth 
700 1 |a Möller, Johannes  |4 oth 
906 |a BOOK 
ADM |b 2024-06-25 01:19:05 Europe/Vienna  |f system  |c marc21  |a 2022-09-22 08:09:39 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5340301290004498&Force_direct=true  |Z 5340301290004498  |b Available  |8 5340301290004498